Qfitlia is part of the
siRNAs class and treats
Hemophilia.
Small interfering ribonucleic acids are used to treat polyneuropathy caused by
hereditary transthyretin-mediated amyloidosis. They also treat
porphyria,
high cholesterol, and various inherited metabolic conditions. They work by stopping the production of certain proteins that cause these medical conditions. Qfitlia is only available as a brand name drug.